Spironolactone for children with NCOR gene changes and autism
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests if spironolactone can help children with autism who have a certain genetic change (in the NCOR gene). The study will monitor improvement and safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be diagnosed with autism based on the ADOS-2 test.
- A genetic test (whole exome) must show a change in the NCOR gene.
- Your child must be between 3 and 10 years old.
- You and your child must agree to take part and allow data and blood/urine samples to be collected.
- Your child cannot have other more serious genetic changes, certain medical conditions, or have taken certain medications recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether omega-3 supplements can help children and teens with autism spectrum disorder (ASD). It aims to see if taking omega-3 improves core symptoms like social communication and behavior.
This trial tests whether a medicine called spironolactone can help children on hemodialysis who still have anemia despite usual treatment. It aims to see if this drug improves red blood cell production better than standard care alone.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
This study tests the drug spironolactone, a medicine that helps your body balance fluids and potassium, in both HIV-positive and HIV-negative adults. The goal is to see how it affects a key protein complex in your cells. If you are HIV-positive, you need to have well-controlled HIV with undetectable virus levels and be on stable treatment.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This Phase 1 study tests whether spironolactone (a medicine that affects salt and hormone balance) is safe and potentially helpful in people with alcohol use disorder. You may be eligible if you are currently drinking heavily, have low alcohol withdrawal symptoms, and meet several lab and medication safety rules.
Hear when a new ASD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.